about
AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatmentEffect of AMP-deaminase 3 knock-out in mice on enzyme activity in heart and other organsAMP-regulated protein kinase activity in the hearts of mice treated with low- or high-fat diet measured using novel LC-MS method.Nucleotide Catabolism on the Surface of Aortic Valve Xenografts; Effects of Different Decellularization Strategies.Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology.Endothelial toxicity of unusual nucleotide metabolites.Influence of 4-pyridone-3-carboxamide-1Β-D-ribonucleoside (4PYR) on activities of extracellular enzymes in endothelial human cells.An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy.Effect of nitrosative stress on extracellular nucleotide metabolism in endothelial cells.4-Pyridone-3-carboxamide-1β-D-ribonucleoside metabolism in endothelial cells and its impact on cellular energetic balance.Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.Effects of 4-Pyridone-3-carboxamide-1β-D-ribonucleoside on adenine nucleotide catabolism in the aortic wall; Implications for atherosclerosis in ApoE-/-LDLR-/- mice.Polymorphism in exon 6 of the human NT5E gene is associated with aortic valve calcification.U937 variant cells as a model of apoptosis without cell disintegration.Metabolic pathway of 4-pyridone-3-carboxamide-1β-d-ribonucleoside and its effects on cellular energetics.Changes in cardiac nucleotide metabolism in Huntington's disease.Effect of decaffeinated coffee on function and nucleotide metabolism in kidney.Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.Deletion of CD73 in mice leads to aortic valve dysfunction.Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.Activity of AMP-regulated protein kinase and AMP-deaminase in the heart of mice fed high-fat diet.Cardioprotective effect of N-methylnicotinamide salt of pyruvate in experimental model of cardiac hypoxia.Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanismsPlasma Nucleotide Dynamics during Exercise and Recovery in Highly Trained Athletes and Recreationally Active IndividualsNucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valvesExtracellular nucleotide catabolism in aortoiliac bifurcation of atherosclerotic ApoE/LDLr double knock out miceExtracellular adenine nucleotide catabolism in heart valvesEffect of 4-pyridone-3-carboxamide ribonucleoside (4PYR)-potential cardiovascular toxin in perfused rat heartIn vitro and cellular effects of 4-pyridone-3-carboxamide riboside on enzymes of nucleotide metabolismActivities of purine converting enzymes in heart, liver and kidney mice LDLR-/- and Apo E-/Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients-Comparison of Serum Metabolome ProfilesCD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralizationThe effects of pro- and anti-atherosclerotic factors on intracellular nucleotide concentration in murine endothelial cellsCharacterization of adenine nucleotide metabolism in the cellular model of Huntington's diseaseVascular extracellular adenosine metabolism in mice correlates with susceptibility to atherosclerosisAlterations in Exercise-Induced Plasma Adenosine Triphosphate Concentration in Highly Trained Athletes in a One-Year Training Cycle
P50
Q26827415-ADB3DF2F-E571-4E03-AF40-836435D651E3Q28587744-85DD6A41-D32A-4557-976A-806BB19ADCE2Q35981623-3D2AC5FE-CEFE-4AAC-B9D3-F49CB472A131Q36795841-6A5B7F47-ED5D-4A7E-B33C-7403FD38156FQ37223938-F7D31A7C-2569-46AE-BC46-F776DFA176FAQ38576785-48D09132-E95C-4670-8B2E-091F5A4822B5Q38576788-72EE1B64-3CEC-4BB3-BBC5-95C9CD780F06Q38576843-02272CFC-CF37-40BF-BBDB-69326F3B9B48Q38728080-7C142640-0E8E-48CA-A75F-C023533CB687Q38827109-EDD5C3F7-F68C-4DB7-9A90-20945E8CB3F4Q38983484-465E4C07-ED17-44CD-899B-636FCE3A4038Q38983486-F8900DE4-9090-4231-B2F7-65026AEE24B2Q38983490-60847D8C-48A6-4029-9664-FB38A74D6130Q39139689-6AD74EFB-17CE-40EB-857E-F25F403A20DDQ39139695-E1B6930B-4E79-4009-8E27-5CE44C287F33Q39162697-D963FA15-5CB7-4144-9D1C-27305901EE0CQ40286131-A5CA63A5-BBE4-45C5-A575-105CBE08B088Q45299252-D159B87C-731A-44F3-83B7-09FB01ECC756Q49202553-8AD3AFE4-846B-4F1E-8B3F-3B21CD633C5FQ50174319-C079BE99-C9FB-4CF2-A344-EBA02026540FQ51140017-6B085677-4105-4499-95FA-B68620E8DFF5Q51292831-A373470B-D532-454A-B555-1B9842D906E1Q53506539-51B59503-11F5-44EF-8AA4-FF80D6A9488EQ54343968-D4CCF782-E0BD-4212-9357-2C41BB4B88E6Q54983715-D4B70E8E-9A29-42AB-B625-21E84B5A503FQ57022088-136B5F76-2865-4F82-977F-8F83EAB3FD5EQ58577734-05D8E11D-7E12-4D16-AA4C-CB421047691BQ67406317-7BBD464F-7792-4CB3-9C2D-DAF3C2E74FD3Q88102575-1BA9B1E4-5285-4081-8A82-D59DCD175972Q88102579-E85FE364-6687-4DFF-943D-012B4F52280FQ88102582-BAEACD99-4D09-4CB7-B44E-47D1E7F6F023Q88102585-D0CCB4E5-1EE6-4F21-B490-25441ECB59B8Q88102594-D06630C1-00F7-4C6B-82D6-DAFA32B4B465Q88752768-4E2D5E5A-A104-4071-AE1B-2828A29E34D6Q89658647-D6618EF4-DEF1-4525-ADDF-E72204B6DC0AQ90591892-A44FC1A9-8B29-477C-8D97-2E4BF3536891Q90761698-949B472A-9B9A-4628-9A5C-34765A227296Q90761719-8022D100-C60F-4DE5-A0E5-1E095CAB264EQ90761784-CEA5E80B-9C13-41C2-9658-B1D8479640F3Q90774282-6BDD8C29-B36B-458D-BC0F-202134DB05D0
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ewa M Slominska
@en
Ewa M Slominska
@nl
Ewa Słomińska
@ast
Ewa Słomińska
@ca
Ewa Słomińska
@cs
Ewa Słomińska
@gl
Ewa Słomińska
@hr
Ewa Słomińska
@hsb
Ewa Słomińska
@it
Ewa Słomińska
@pl
type
label
Ewa M Slominska
@en
Ewa M Slominska
@nl
Ewa Słomińska
@ast
Ewa Słomińska
@ca
Ewa Słomińska
@cs
Ewa Słomińska
@gl
Ewa Słomińska
@hr
Ewa Słomińska
@hsb
Ewa Słomińska
@it
Ewa Słomińska
@pl
prefLabel
Ewa M Slominska
@en
Ewa M Slominska
@nl
Ewa Słomińska
@ast
Ewa Słomińska
@ca
Ewa Słomińska
@cs
Ewa Słomińska
@gl
Ewa Słomińska
@hr
Ewa Słomińska
@hsb
Ewa Słomińska
@it
Ewa Słomińska
@pl
P214
P1412
P1559
Ewa Słomińska
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-3037-1844